
11-15-2003, 11:14 AM
|
| Member | | Join Date: Nov 2003 Location: World Wide Web
Posts: 104
| |
INGAP Comments
Here is another article that I think has better info on INGAP
It not only represents a possible cure for diabetes,
but it is equally applicable to Type 1 or Type 2.
And, it has already worked,
on mice and hamsters.
They are now starting Phase II studies in humans.
I will post the link for sign-up info if I come across it.
It is at selected centers in some parts of the US.
The most notable thing about this is that
although it is the closest we have come to a
bonafide cure for diabetes, without the
immune/rejection problems associated with transplants,
it is not something that the big drug companies
and manufacturers of diabetes supplies want to
have happen !
Lilly makes over a billion dollars per year from the
sale of Humulin insulin alone, and
several billion more from the sale of its other
diabetic supplies and oral medicines.
Think that they want to lose that?
Lilly actually got in on the INGAP research in 1997,
and then backed out two years later, stating
that it was not in their future interests,
primarily to their stockholders.
Now Protor & Gamble has put themselves in it
with a measly $6 million for research.
Do you know how much Squibb has paid for
the rights to continue research on Basulin,
a new insulin still in the development stages,
but which Squibb hopes to make a pile of money
from? $20 million up front, and an additional
$145 million, for a total of $165 million !
Meanwhile, the soap & powder company has
invested only $6 million for a potential cure.
(They do have a pharmaceutical division.)
Big Biz does not want a cure for diabetes,
even though it may be out there. |